MS-TRACE has been developed by the department of Medical Microbiology and Infection prevention at the Amsterdam UMC. The researchers involved with the development and maintenance of MS-TRACE are listed below.

Drs. Jelle Koopsen

PhD candidate at the Lab of Applied Evolutionary Biology, Amsterdam UMC
Get in touch

Dr. Janke Schinkel

Head of the Section of Clinical Virology at the Amsterdam UMC
Get in touch

Dr. Marc van der Valk

Head of the HIV clinic at the Amsterdam UMC

Drs. Maarten Pater

Software Engineer at the
Amsterdam UMC

Professor Colin Russell

Professor of Applied Evolutionary Biology at the Amsterdam UMC


MS-TRACE would not have been possible without the generous help, advice, and sharing of data from our partners and collaborators. The MS-TRACE team acknowledges the following people for their continued support:

GGD Amsterdam
Maria Prins
Lian Boveé
Titia Heijmans
Elske Hoornenborg

Eline op de Coul

Thijs van de Laar

Patrick Ingiliz
Stephan Grunwald
Martin Däumer
Christoph Boesecke

APHP Paris
Karine LaCombe
Hayette Rougier

Project and Funding

In order to eliminate HCV from the MSM population, more information is needed on international transmission dynamics to identify the sources and timing of new HCV infections. MS-TRACE is developed as part of a larger NoCo (HCV/HIV No Co-Infection) project, funded by Gilead Sciences. In this NoCo project we have three components to aid efforts towards micro-elimination of HCV in HIV-infected and high-risk HIV-uninfected populations. The first component is the development of this MS-TRACE platform. The other two components are the analysis of retrospectively and prospectively collected samples from MSM with an acute or recently acquired HCV infection in Amsterdam, Berlin, and Paris. We are currently working on the sequencing of these samples and in future updates of MS-TRACE, they will be incorporated.